Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COXFA4P3 is a *pseudogene* classified among noncoding genomic elements related to the NDUFA4 (COXFA4) gene, itself a nuclear-encoded subunit of cytochrome c oxidase (Complex IV) of the mitochondrial respiratory chain[2][4]. Pseudogenes like COXFA4P3 do not code for functional proteins, but recent studies show some pseudogenes can have regulatory roles in gene expression through mechanisms such as acting as decoys for microRNAs or being processed into small RNAs that influence gene silencing pathways[1]. However, no experimental or literature evidence shows that COXFA4P3 specifically acts as a functional regulator, disease marker, or drug target. There is no documentation of drug interaction, mechanism of action, or established biomarker status for COXFA4P3.\n\nIn summary, **COXFA4P3 is not a canonical therapeutic target** and its classification as a pseudogene means it is not generally of direct pharmacological interest, nor is it associated with clinical safety concerns, drug interactions, or defined disease roles. If you intended to catalog functional COX subunits, the *active target would be NDUFA4 (COXFA4), not COXFA4P3* (the pseudogene)[2].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COXFA4 pseudogene 3 (COXFA4P3).